StockData
MariMed Inc. logo

MariMed Inc. (MRMD) stock

MRMDOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 1/30
$0.06−0.00 (-3.39%)

Close on Oct 19, 2026Market cap $22.78MP/E –Yield –

MariMed gross margin

Gross margin is gross profit as a percentage of revenue.

MariMed's gross margin for the twelve months ending Jun 30, 2026 was 35.6%. For fiscal 2025 it was 36.2%, against 39.7% the year before. The highest annual figure on record is 65.9% in fiscal 2018.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202536.2%−3.5
FY2024Dec 31, 202439.7%−4.7
FY2023Dec 31, 202344.4%−3.4
FY2022Dec 31, 202247.7%−6.8
FY2021Dec 31, 202154.6%−7.0
FY2020Dec 31, 202061.5%+20.5
FY2019Dec 31, 201941.0%−24.9
FY2018Dec 31, 201865.9%+2.0
FY2017Dec 31, 201763.9%+9.2
FY2016Dec 31, 201654.6%+78.0
FY2015Dec 31, 2015-23.4%+91.8
FY2014Dec 31, 2014-115.2%+2692.5
FY2013Dec 31, 2013-2807.6%−366.5
FY2012Dec 31, 2012-2441.1%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202638.7%−1.6
Q1 FY2026Mar 31, 202638.7%−1.1
Q4 FY2025Dec 31, 202525.2%−7.3
Q3 FY2025Sep 30, 202540.1%−1.2
Q2 FY2025Jun 30, 202540.3%−1.5
Q1 FY2025Mar 31, 202539.8%−3.6
Q4 FY2024Dec 31, 202432.5%−12.0
Q3 FY2024Sep 30, 202441.3%−2.1
Q2 FY2024Jun 30, 202441.8%−3.0
Q1 FY2024Mar 31, 202443.4%−1.3
Q4 FY2023Dec 31, 202344.5%+0.4
Q3 FY2023Sep 30, 202343.4%−4.3
Q2 FY2023Jun 30, 202344.8%−0.6
Q1 FY2023Mar 31, 202344.8%−9.5
Q4 FY2022Dec 31, 202244.1%−5.8
Q3 FY2022Sep 30, 202247.7%−5.8
Q2 FY2022Jun 30, 202245.5%−11.6
Q1 FY2022Mar 31, 202254.3%−10.2
Q4 FY2021Dec 31, 202149.9%−14.2
Q1 FY2021Mar 31, 202153.5%−11.7
Q4 FY2020Dec 31, 202057.1%+2.9
Q3 FY2020Sep 30, 202064.5%+22.6
Q2 FY2020Jun 30, 202064.1%+29.3
Q1 FY2020Mar 31, 202065.2%+0.9
Q4 FY2019Dec 31, 201954.2%−25.0
Q3 FY2019Sep 30, 201941.9%−13.3
Q2 FY2019Jun 30, 201934.8%−34.1
Q1 FY2019Mar 31, 201964.3%+7.0
Q4 FY2018Dec 31, 201879.2%+23.7
Q3 FY2018Sep 30, 201855.1%−12.9
Q2 FY2018Jun 30, 201868.9%−2.1
Q1 FY2018Mar 31, 201857.3%−1.7
Q4 FY2017Dec 31, 201755.4%+1.9
Q3 FY2017Sep 30, 201768.0%+16.4
Q2 FY2017Jun 30, 201771.1%+4.2
Q1 FY2017Mar 31, 201759.1%–
Q4 FY2016Dec 31, 201653.5%–
Q3 FY2016Sep 30, 201651.6%–
Q2 FY2016Jun 30, 201666.9%–

More MariMed figures

See a number that looks wrong?